Physician profile
Robert Schergen
NPI 1023469277
$14,584.60
in general payments reported to CMS, 2019-2025
10 companies · $547 in 2025
The $547 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,162 · 2020: $7,627 · 2021: $1,200 · 2022: $278 · 2023: $197 · 2024: $575 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,318.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $5,443.27 | 2019-2020 | |
| Elite Orthopedics, LLC | $4,279.00 | 2019-2021 | |
| Stryker Corporation | $4,040.94 | 2019-2025 | Easyfuse, Allofiber, Augment Injectable |
| Depuy Synthes Sales INC. | $353.79 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $178.04 | 2020 | |
| Spr Therapeutics, INC | $153.07 | 2023-2025 | Sprint Pns System |
| Medtronic, INC. | $49.66 | 2022 | |
| Aroa Biosurgery Incorporated | $42.80 | 2025 | |
| Integra Lifesciences Corporation | $29.79 | 2019 | |
| Boston Scientific Corporation | $14.24 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schergen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.